EMA addendum addresses vaccine development for immunocompromised people
Regulatory NewsFerdous Al-Faruque
Clinical Trials Regulation EuropeEuropean Medicines Agency (EMA)GuidancePharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsFerdous Al-FaruqueClinical Trials Regulation EuropeEuropean Medicines Agency (EMA)GuidancePharmaceuticalsRegulatory Intelligence/Policy